Trials / Conditions / Soft Tissue Sarcoma (STS)

Soft Tissue Sarcoma (STS)

20 registered clinical trials studyying Soft Tissue Sarcoma (STS) — 18 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	5-AminoLevulinic Acid Aided Resection Margins in Sarcoma NCT07038278	University of Colorado, Denver	EARLY_Phase 1
Not Yet Recruiting	Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02) NCT07396116	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Not Yet Recruiting	A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety NCT07342322	First Affiliated Hospital of Guangxi Medical University	Phase 2
Recruiting	Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarc NCT07173972	Oslo University Hospital	Phase 2
Not Yet Recruiting	A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlot NCT07205185	Fudan University	Phase 2
Recruiting	Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961	Institut Claudius Regaud	N/A
Not Yet Recruiting	EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovar NCT06748872	Medigene AG	Phase 1
Recruiting	Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma NCT06980259	Shandong Cancer Hospital and Institute	N/A
Recruiting	Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor NCT06774729	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Recruiting	BAL Fluid Biomarkers in Sarcoma NCT06815666	University Health Network, Toronto	Phase 2
Recruiting	Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas NCT07032285	Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas	Phase 2
Not Yet Recruiting	ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. NCT06699576	Hansoh BioMedical R&D Company	Phase 1
Recruiting	PET-imaging of Two Vartumabs in Patients With Solid Tumors NCT06645808	Var2 Pharmaceuticals	EARLY_Phase 1
Not Yet Recruiting	First-line Treatment of Advanced/unresectable DDLPS NCT06694324	Fudan University	Phase 2
Recruiting	Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study NCT06848582	Sun Yat-sen University	N/A
Recruiting	SAVE Studie- SArcoma Surgery With Vacuum Enhanced Wound Treatment Randomised Study to Evaluate the Wound Manag NCT06889532	Universitätsklinikum Hamburg-Eppendorf	N/A
Recruiting	A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Co NCT05824975	GI Innovation, Inc.	Phase 1 / Phase 2
Recruiting	Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932	Royal Marsden NHS Foundation Trust	—
Completed	Saving Limbs After Cancer: Blood Vessel and Soft Tissue Reconstruction Following Sarcoma Surgery in the Legs NCT07093320	European Georges Pompidou Hospital	—
Unknown	Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue S NCT01594203	Hadassah Medical Organization	—